Nurse Practitioner in Henrietta, TX Accepting Medicare

3 Nurse Practitioner nurses found. Showing 1 - 3

Jessica Denea Lander, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 310 W South St, Henrietta, TX 76365 Phone: 940-538-5621

Cari Howard, FNP B-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 102 S Archer St, Henrietta, TX 76365 Phone: 940-538-0454

Susan Persick, NP Nurse Practitioner - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 310 W South St, Henrietta, TX 76365 Phone: 940-538-5621    Fax: 940-235-1215

News Archive

FDA-approved metformin can prevent tobacco-carcinogen induced lung tumors: Study

Metformin, a mainstay of treatment for patients with type 2 diabetes, may soon play a role in lung cancer prevention if early laboratory research presented here at the AACR 101st Annual Meeting 2010 is confirmed in clinical trials.

Persistent fatigue immediately following birth may be the best predictor of postpartum depression

Persistent fatigue immediately following birth may be the best signal to determine whether a woman will develop postpartum depression, a new study suggests.

Individual genes and networks that play an important role in inflammation, atherosclerosis identified

HemoShear, LLC, a leading developer of innovative, cell-based, human surrogate models for discovery and assessment of new drug compounds, has produced a profile of all of the genes that influence the biology and function of the human artery system. This research has generated valuable information on the entire spectrum of genes that are found in specific cell-types that make up human arteries.

The Sandbox Project aims to improve health and wellbeing of Canadian children

Canada's leaders are playing in the sandbox to build a healthier generation of Canadians. In order to raise awareness about The Sandbox Project, Canadian Members of Parliament, Cabinet Ministers, media personalities, NGO's, families and industry professionals built sandcastles in the World's Largest Sandbox event on Sparks Street in Ottawa on Wednesday.

Shield Therapeutics recruits patients for ST10 Phase 3 study for treating iron-deficient anaemia

Shield Therapeutics, the independent specialty mineral medicines pharmaceutical company, today announces that it has completed recruitment of patients into its pivotal Phase 3 programme of ST10 for the treatment of iron-deficient anaemia. ST10 is a novel form of ferric iron taken orally.

Read more Medical News

› Verified 3 days ago